Belgium

From BioPolicyWiki
Jump to: navigation, search
Belgium
Belgium-flag.jpg
Information
Region Europe
Population 10584534
GDP (millions USD) 453,636
National Policies
Eggs for assisted reproduction commercial prohibited
Eggs for research commercial prohibited
Inheritable genetic modification PROHIBITED
Preimplantation genetic diagnosis social uses prohibited
Reproductive cloning PROHIBITED
Research cloning regulated
Sex selection ?
Surrogacy commercial prohibited
International Agreements
1997 COE Biomedicine Convention not signed
1998 COE Cloning Convention not signed
2005 UN Cloning Vote no
2005 UNESCO Sports Doping Convention RATIFIED
2007 Treaty of Lisbon signed


Contents

Key laws and policies

Foundational values

The Law on Research into Embryos expresses a belief in the importance of freedom of research and the acceptance of ethical pluralism in society.

Prohibited practices

The Law on Research into Embryos prohibits:

  • Reproductive cloning
  • Conducting research or treatment for eugenic purposes, i.e. PGD or genetic modification for enhancement or for social purposes
  • Sex selection for non-medical purposes
  • Using embryos, gametes, and embryonic stem cells for commercial purposes
  • Placing human embryos in animals
  • Creating chimeras or hybrids
  • Placing embryos on which research has been conducted in humans, except when the research had a therapeutic benefit for the embryo itself or when it concerns an observation method that does not harm the embryo’s integrity

Commercial surrogacy is prohibited on public policy grounds.

Permitted and regulated practices

The Law on Research into Embryos appears to affirm all types of research directed at therapeutic purposes and increased medical knowledge. Implicitly, the creation of embryos for research is also allowed.

Couples seeking PGD must be seen by psychologists and counseled regarding the welfare of the future child, the family context, and parenting abilities before the procedure is approved.

Research on embryos in vitro is allowed if:

  1. The research has a therapeutic purpose or contributes to a better knowledge about fertility, infertility, organ and tissue transplantation, and prevention or treatment of diseases.
  2. The research is founded on the most recent scientific findings and conforms to the requirements of correct scientific methodology.
  3. The research is conducted in a licensed laboratory that is linked to an academic program for assisted reproduction or human genetics and is performed in appropriate technical and material conditions.
  4. The research is conducted under the supervision of a specialist or a qualified person.
  5. The research is performed on embryos during the first 14 days of development, the period of freezing not included.
  6. There is no other research method that is equally efficient.

Note: Approval needed by local Institutional Review Board (IRB) and by Federal Commission for Embryo Research. Dual approval is needed.


  • Gamete (sperm and eggs) and embryo donation for assisted reproduction is permitted (albeit generally anonymous, with some provision now for known donors).
  • Gamete donation is non-commercial (although expenses made by the donor – e.g. travel costs or loss of income – must be reimbursed).
  • Altruistic surrogacy is not regulated and therefore possible. (Note: Contracts are not enforceable and adoption is required to transfer legal parenthood; a small number of such arrangements occur in the country each year.)

Regulatory activities

Assisted Reproductive Technology centers must obtain a license to practice, provide annual reports, and work with one of eight human genetic centers established at the eight medical faculties in Belgium. The centers decide autonomously for which conditions and therapeutic purposes (e.g. HLA-typing) they will offer PGD and to whom.

The Law on Research into Embryos requires that embryo research be approved by a local ethics committee of the academic institute and the Federal Commission for medical and scientific research on embryos in vitro. The Commission rules with a two-thirds majority.

Every embryo researcher sends a report on the progress of his/her research to the Commission. This report includes:

  • The purpose, methodology, and time period of the research
  • The manner in which the provisions of the law were respected
  • The advice of the local ethics committee
  • The progress of the research

The Commission also collects and centralizes information on the different projects on embryos in vitro and issues recommendations for future legislative initiatives or other measures.

Accountability and governance

The Law on Research into Embryos requires that the Federal Commission for medical and scientific research on embryos in vitro reports to the legislative chambers.

History

Belgium was one of the last countries in the European Union to regulate PGD and embryo research by law. Until 1999, PGD was permitted unregulated without license.

References